生物谷
(833266)
| 流通市值：6.97亿 | | | 总市值：11.23亿 |
| 流通股本：7693.51万 | | | 总股本：1.24亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 227,187,187.28 | 230,760,200.35 | 205,555,244.94 | 155,106,733.08 |
| 应收票据及应收账款 | 99,272,534.29 | 99,598,352.56 | 125,633,607.31 | 142,342,325.1 |
| 其中：应收票据 | 6,827,116.21 | 2,709,455.28 | 7,053,675.82 | 10,502,395.12 |
| 应收账款 | 92,445,418.08 | 96,888,897.28 | 118,579,931.49 | 131,839,929.98 |
| 应收款项融资 | 18,711,798.5 | 21,401,508.67 | 35,007,607.27 | 41,130,474.36 |
| 预付款项 | 3,960,218.17 | 3,245,812.86 | 4,534,147.06 | 2,773,039.3 |
| 其他应收款合计 | 115,764,218.26 | 115,726,107 | 126,227,925.74 | 126,283,279.14 |
| 存货 | 107,993,088.15 | 104,490,752.62 | 98,256,192.51 | 108,244,983.82 |
| 一年内到期的非流动资产 | 220,291.85 | 216,521.3 | 54,520.53 | 51,167.05 |
| 其他流动资产 | 6,407,207.79 | 6,152,891.06 | 5,896,258.08 | 10,444,474.59 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 629,640,571 | 631,716,173.13 | 652,234,274.26 | 637,445,247.26 |
| 非流动资产: | | | | |
| 长期应收款 | 29,574,668.07 | 29,572,868.49 | 29,456,366.88 | 29,457,662.12 |
| 其他非流动金融资产 | 12,500,000 | 12,500,000 | 12,500,000 | 12,500,000 |
| 固定资产 | 283,933,805.44 | 287,936,565.83 | 291,750,061.14 | 295,744,348.58 |
| 在建工程 | 126,682,566.97 | 123,850,929.37 | 122,898,300.05 | 122,373,341.7 |
| 使用权资产 | 2,975,963.6 | 4,228,402.83 | 7,567,252.07 | 9,836,351.24 |
| 无形资产 | 92,266,915 | 92,949,360.7 | 93,631,806.4 | 94,428,029.09 |
| 递延所得税资产 | 30,546,854.19 | 30,809,131.6 | 29,420,362.71 | 30,061,315.52 |
| 其他非流动资产 | 5,977,948.52 | 5,384,771.47 | 5,551,726.7 | 3,855,926.33 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 584,458,721.79 | 587,232,030.29 | 592,775,875.95 | 598,256,974.58 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,214,099,292.79 | 1,218,948,203.42 | 1,245,010,150.21 | 1,235,702,221.84 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 31,745,507.8 | 30,964,245.51 | 29,800,085.08 | 28,576,021.95 |
| 应付账款 | 31,745,507.8 | 30,964,245.51 | 29,800,085.08 | 28,576,021.95 |
| 合同负债 | 1,787,922.47 | 1,664,962.82 | 1,129,333.07 | 2,973,295.69 |
| 应付职工薪酬 | 2,781,288.6 | 4,410,634.83 | 4,278,944.87 | 11,370,571.1 |
| 应交税费 | 7,771,355.32 | 4,994,781.08 | 8,357,438.85 | 5,003,380.8 |
| 其他应付款合计 | 18,713,541.76 | 19,538,654.74 | 21,350,688.55 | 13,227,286.86 |
| 一年内到期的非流动负债 | 31,301,771.91 | 34,802,346.65 | 33,565,564.31 | 35,736,756.75 |
| 其他流动负债 | 1,431,020.94 | 500,570.98 | 1,374,695.97 | 2,216,767.66 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 95,532,408.8 | 96,876,196.61 | 99,856,750.7 | 99,104,080.81 |
| 非流动负债: | | | | |
| 长期借款 | 37,500,000 | 37,500,000 | 52,500,000 | 52,500,000 |
| 租赁负债 | 815,438.6 | 626,557.22 | 1,194,337.8 | 1,362,441.97 |
| 递延收益 | 78,721,871.05 | 79,646,904.23 | 81,291,231.57 | 83,097,133.23 |
| 递延所得税负债 | 260,807.85 | 18,604.01 | 160,315.62 | 160,315.62 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 117,298,117.5 | 117,792,065.46 | 135,145,884.99 | 137,119,890.82 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 212,830,526.3 | 214,668,262.07 | 235,002,635.69 | 236,223,971.63 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 124,000,007 | 124,000,007 | 124,000,007 | 124,000,007 |
| 资本公积 | 396,600,116.59 | 396,600,116.59 | 396,600,116.59 | 396,600,116.59 |
| 减:库存股 | 5,140,700.12 | 5,140,700.12 | 5,140,700.12 | 5,140,700.12 |
| 盈余公积 | 68,242,259.73 | 68,242,259.73 | 68,242,259.73 | 68,242,259.73 |
| 未分配利润 | 417,567,083.29 | 420,578,258.15 | 426,305,831.32 | 415,776,567.01 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,001,268,766.49 | 1,004,279,941.35 | 1,010,007,514.52 | 999,478,250.21 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,001,268,766.49 | 1,004,279,941.35 | 1,010,007,514.52 | 999,478,250.21 |
| 负债和股东权益合计 | 1,214,099,292.79 | 1,218,948,203.42 | 1,245,010,150.21 | 1,235,702,221.84 |
| 公告日期 | 2024-10-29 | 2024-08-26 | 2024-04-29 | 2024-04-29 |
| 审计意见(境内) | | | | 保留意见 |